Geert Ensing

825 total citations
15 papers, 647 citations indexed

About

Geert Ensing is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Surgery. According to data from OpenAlex, Geert Ensing has authored 15 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Geert Ensing's work include Radiopharmaceutical Chemistry and Applications (8 papers), Neuroendocrine Tumor Research Advances (4 papers) and Orthopedic Infections and Treatments (4 papers). Geert Ensing is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), Neuroendocrine Tumor Research Advances (4 papers) and Orthopedic Infections and Treatments (4 papers). Geert Ensing collaborates with scholars based in Netherlands, United Kingdom and Sweden. Geert Ensing's co-authors include Willem H. Bakker, Marion de Jong, Wout A. P. Breeman, Eric P. Krenning, Frank H. de Jong, Roelf Valkema, Pieternella J. Lugtenburg, Mats Stridsberg, Jan Lindemans and Wouter W. de Herder and has published in prestigious journals such as Communications of the ACM, European Journal of Nuclear Medicine and Molecular Imaging and Seminars in Nuclear Medicine.

In The Last Decade

Geert Ensing

15 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geert Ensing Netherlands 8 348 306 302 204 97 15 647
R. P. Baum Germany 14 177 0.5× 237 0.8× 368 1.2× 122 0.6× 113 1.2× 77 644
Andréa Moretti Italy 14 118 0.3× 208 0.7× 213 0.7× 78 0.4× 286 2.9× 36 650
Lucia Martiniova United States 14 130 0.4× 183 0.6× 244 0.8× 166 0.8× 55 0.6× 26 980
Daniel Yakar United States 12 96 0.3× 56 0.2× 128 0.4× 63 0.3× 183 1.9× 20 462
Ashok Panneerselvam United States 16 250 0.7× 330 1.1× 31 0.1× 142 0.7× 201 2.1× 33 678
Sibylle Haraida Germany 8 202 0.6× 54 0.2× 151 0.5× 20 0.1× 103 1.1× 12 528
Theo H. M. Falke Netherlands 12 96 0.3× 70 0.2× 140 0.5× 32 0.2× 47 0.5× 18 485
Christian Stremmel Germany 13 60 0.2× 223 0.7× 93 0.3× 46 0.2× 289 3.0× 25 650
Yi‐Ting Yen Taiwan 15 73 0.2× 183 0.6× 80 0.3× 89 0.4× 314 3.2× 80 760
Gustavo Reynoso United States 12 97 0.3× 326 1.1× 207 0.7× 15 0.1× 205 2.1× 28 708

Countries citing papers authored by Geert Ensing

Since Specialization
Citations

This map shows the geographic impact of Geert Ensing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Ensing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Ensing more than expected).

Fields of papers citing papers by Geert Ensing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Ensing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Ensing. The network helps show where Geert Ensing may publish in the future.

Co-authorship network of co-authors of Geert Ensing

This figure shows the co-authorship network connecting the top 25 collaborators of Geert Ensing. A scholar is included among the top collaborators of Geert Ensing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geert Ensing. Geert Ensing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Verberne, Hein J., Ellinor Busemann Sokole, Geert Ensing, et al.. (2008). Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity. European Journal of Nuclear Medicine and Molecular Imaging. 35(4). 798–807. 7 indexed citations
2.
Ensing, Geert, et al.. (2004). ODC. Communications of the ACM. 47(5). 47–49. 6 indexed citations
3.
McClelland, C. M., Martin J. Leahy, Michael O’Doherty, et al.. (2003). 99mTc-SnF2 colloid ‘LLK’: particle size, morphology and leucocyte labelling behaviour. Nuclear Medicine Communications. 24(2). 191–202. 12 indexed citations
4.
Valkema, Roelf, Marion de Jong, Willem H. Bakker, et al.. (2002). Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience. Seminars in Nuclear Medicine. 32(2). 110–122. 328 indexed citations
5.
Valkema, Roelf, Marion de Jong, Willem H. Bakker, et al.. (2002). Phase I Study of Peptide Receptor Radionuclide Therapy With (lllIn-DTPA~. 2 indexed citations
6.
Bernard, Bert F., Eric P. Krenning, Wout A. P. Breeman, et al.. (1998). 99mTc-MIBI, 99mTc-Tetrofosmin and 99mTc-Q12 In Vitro and In Vivo. Nuclear Medicine and Biology. 25(3). 233–240. 43 indexed citations
7.
Blankenstein, Marinus A., et al.. (1997). Biodistribution of 123I-Labeled 4-hydroxytamoxifen derivatives in rats with dimethylbenzanthracene-induced mammary carcinomas. Nuclear Medicine and Biology. 24(8). 719–722. 3 indexed citations
8.
Jong, Marion de, Bert F. Bernard, Wout A. P. Breeman, et al.. (1996). Comparison of uptake of99mTc-MIBI,99mTc-tetrofosmin and99mTc-012 into human breast cancer cell lines. European Journal of Nuclear Medicine and Molecular Imaging. 23(10). 1361–1366. 39 indexed citations
9.
Eersels, Jos, et al.. (1995). A simple and efficient method to remove free radioiodide from *I-radiopharmaceuticals. European Journal of Nuclear Medicine and Molecular Imaging. 22(10). 1185–1186. 7 indexed citations
10.
Bakker, Willem H., Leo J. Hofland, T. J. Visser, et al.. (1995). Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.. PubMed. 36(4). 623–7. 74 indexed citations
11.
Calame, Wim, et al.. (1991). Binding of99mTc-labelled polyclonal human immunoglobulin to bacteria as a mechanism for scintigraphic detection of infection. European Journal of Nuclear Medicine and Molecular Imaging. 18(6). 396–400. 27 indexed citations
12.
Calame, Wim, et al.. (1991). Detection of a local staphylococcal infection in mice with technetium-99m-labeled polyclonal human immunoglobulin.. PubMed. 32(3). 468–74. 25 indexed citations
13.
Buscombe, John, et al.. (1990). 99mTc-human immunoglobulin (HIG) — first results of a new agent for the localization of infection and inflammation. European Journal of Nuclear Medicine and Molecular Imaging. 16(8-10). 649–655. 68 indexed citations
14.
Ensing, Geert & M. R. Halie. (1986). In vitro function of radiocolloid-labelled monocytes. European Journal of Nuclear Medicine and Molecular Imaging. 12(4). 163–167. 2 indexed citations
15.
Vellenga, Edo, Geert Ensing, M. R. Halie, et al.. (1983). Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria. Annals of Hematology. 47(2). 77–83. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026